+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Cardiac Biomarker Diagnostic Kits Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2019 To 2027

  • ID: 4992306
  • Report
  • February 2020
  • Region: Global
  • Acute Market Reports
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories
  • Alere, Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories
  • Danaher Corporation
  • Hoffmann-La Roche AG
  • MORE
The cardiac biomarker diagnostic kits market was valued at US$ 2,106.4 Mn in 2018, expected to grow at a CAGR of 5.3% during the forecast period from 2019 to 2027.

Market Insights

The global cardiac biomarker diagnostic kits market is growing competently from 2019 to 2027 attributed to an increase in prevalence for cardiac diseases, and other lifestyle diseases in the geriatric population. Increased FDA clearance for new cardiac diagnostic kits along with automated systems will enhance the overall market growth in the diagnostics industry. New technology expansion, acquisitions, and novel product launch will drive the market in developed nations globally. Cardiac biomarker diagnostic kits further categorized into product types, disease indication, and testing. Angina pectoris in the disease indication shows a huge opportunity globally.

Launch of ultra-sensitive cardiac troponin-I kits and assays along with improved clinical outcomes will generate maximum revenue share globally. Enhanced guidelines in the manufacturing of diagnostic kits will enhance the overall production. A high prevalence of the atherosclerotic vascular disease will have a huge impact on a global scale. As per the data by WHO, more than 30% of the mortality rate is due to this CVD. Moreover, as per the American Heart Association, in a 2016 study, the total direct medical expenditure of cardiovascular diseases estimated to increase by more than $700 billion in 2035. More than 500,000 new cases of angina pectoris registered every year in the U.S., henceforth, driving the market growth in the North America region.

Top organizations are mainly focusing on novel product launch along with increased FDA approval in the U.S. market. An increasing number of admissions with myocardial infarction (mi), cardiac heart failure and angina pectoris in the hospitals and diagnostic centers will increase the demand for cardiac biomarker diagnostic kits globally. The troponin test kit along with the BNP test kit will hold a major revenue share globally. Angina Pectoris in the disease indication segment will contribute a significant revenue share on a global scale.

The U.S. market is leading globally accredited to increasing the commonness of CVD, chronic diseases, increasing elderly population with unmet needs, and domicile of top diagnostic kit manufacturers in the United States. Major factors accountable for the overall market growth include expansion in point of care testing, increased awareness related to CVD, and increased usage of Troponin I and T kits with progressive techniques globally.

Key Market Movements:
  • Globally, the cardiac biomarker diagnostic kits are growing at a CAGR of 5.3% for the period from 2019 to 2027
  • Better general health awareness for CVD along with improved treatment and diagnostic options will drive the market growth in the Asia Pacific and MEA region owing to progress in overall medical care, increase in medical expenditure, and medical tourism
  • Increased funding by public and private organizations for better quality medical treatment
  • U.S FDA approval, novel diagnostic kit launch along with promising pipeline products for AMI, angina, and other cardiac conditions will drive the market growth.
Key Market Players
  • bioMerieux SA
  • Danaher Corporation
  • Guangzhou Wondfo Biotech Co., Ltd
  • Siemens AG
  • Abbott Laboratories
  • Alere, Inc.
  • LSI Medience Corporation
  • Randox laboratories
  • Ortho Clinical Diagnostics
  • Hoffmann-La Roche AG
  • Thermofisher Scientific
  • Bio-Rad Laboratories
  • Others
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Alere, Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories
  • Danaher Corporation
  • Hoffmann-La Roche AG
  • MORE
1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.4. Market Segmentation

2. Executive Summary
2.1. Market Snapshot: Global CBDK Market
2.2. Global CBDK Market, by Product Type, 2018 (US$ Mn)
2.3. Global CBDK Market, by Disease Indication, 2018 (US$ Mn)
2.4. Global CBDK Market, by Testing, 2018 (US$ Mn)
2.5. Global CBDK Market, by Geography, 2018 (US$ Mn)

3. Market Dynamics
3.1. Introduction
3.1.1. Global CBDK Market Value, 2017-2027, (US$ Mn)
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.2. Market Restraints
3.3. Attractive Investment Proposition, by Geography, 2018
3.4. Market Positioning of Key Players, 2018
3.4.1. Major Strategies Adopted by Key Players

4. Global Cardiac Biomarker Diagnostic Kits (CBDK) Market, by Product Type , 2017-2027 (US$ Mn)
4.1. Overview
4.2. Troponin Test Kits
4.3. CK-MB Test Kits
4.4. Myoglobin Test Kits
4.5. BNP Test Kit
4.6. C-reactive Protein (hsCRP)
4.7. Other Biomarkers

5. Global Cardiac Biomarker Diagnostic Kits (CBDK) Market, by Disease Indication, 2017-2027 (US$ Mn)
5.1. Overview
5.2. Angina Pectoris
5.3. Myocardial Infraction (MI)
5.4. Cardiac Heart Failure

6. Global Cardiac Biomarker Diagnostic Kits (CBDK) Market, by Testing, 2017-2027 (US$ Mn)
6.1. Laboratory Testing
6.2. Point of Care Testing

7. North America Cardiac Biomarker Diagnostic Kits (CBDK) Market Analysis, 2017-2027 (US$ Mn)
7.1. Overview
7.1.1. North America CBDK Market Value and Growth, 2017-2027, (US$ Mn)
7.2. North America CBDK Market Value, By Product Type, 2017-2027 (US$ Mn)
7.2.1. Market Analysis
7.3. North America CBDK Market Value, By Disease Indication, 2017-2027 (US$ Mn)
7.3.1. Market Analysis
7.4. North America CBDK Market Value, By Testing, 2017-2027 (US$ Mn)
7.4.1. Market Analysis
7.5. North America CBDK Market Value, By Region/Country, 2017-2027 (US$ Mn)
7.5.1. Market Analysis
7.5.2. U.S.
7.5.3. Rest of North America

8. Europe Cardiac Biomarker Diagnostic Kits (CBDK) Market Analysis, 2017-2027 (US$ Mn)
8.1. Overview
8.1.1. Europe CBDK Market Value and Growth, 2017-2027, (US$ Mn)
8.2. Europe CBDK Market Value, By Product Type, 2017-2027 (US$ Mn)
8.2.1. Market Analysis
8.3. Europe CBDK Market Value, By Disease Indication, 2017-2027 (US$ Mn)
8.3.1. Market Analysis
8.4. Europe CBDK Market Value, By Testing, 2017-2027 (US$ Mn)
8.4.1. Market Analysis
8.5. Europe CBDK Market Value, By Region/Country, 2017-2027 (US$ Mn)
8.5.1. Market Analysis
8.5.2. U.K.
8.5.3. Germany
8.5.4. France
8.5.5. Italy
8.5.6. Rest of Europe

9. Asia Pacific Cardiac Biomarker Diagnostic Kits (CBDK) Market Analysis, 2017-2027 (US$ Mn)
9.1. Overview
9.1.1. Asia Pacific CBDK Market Value and Growth, 2017-2027, (US$ Mn)
9.2. Asia Pacific CBDK Market Value, By Product Type, 2017-2027 (US$ Mn)
9.2.1. Market Analysis
9.3. Asia Pacific CBDK Market Value, By Disease Indication, 2017-2027 (US$ Mn)
9.3.1. Market Analysis
9.4. Asia Pacific CBDK Market Value, By Testing, 2017-2027 (US$ Mn)
9.4.1. Market Analysis
9.5. Asia Pacific CBDK Market Value, By Region/Country, 2017-2027 (US$ Mn)
9.5.1. Market Analysis
9.5.2. Japan
9.5.3. China
9.5.4. India
9.5.5. Rest of Asia Pacific

10. Rest of the World Cardiac Biomarker Diagnostic Kits (CBDK) Market Analysis, 2017-2027 (US$ Mn)
10.1. Overview
10.1.1. Rest of the World CBDK Market Value and Growth, 2017-2027, (US$ Mn)
10.2. Rest of the World CBDK Market Value, By Product Type, 2017-2027 (US$ Mn)
10.2.1. Market Analysis
10.3. Rest of the World CBDK Market Value, By Disease Indication, 2017-2027 (US$ Mn)
10.3.1. Market Analysis
10.4. Rest of the World CBDK Market Value, By Testing, 2017-2027 (US$ Mn)
10.4.1. Market Analysis
10.5. Rest of the World CBDK Market Value, By Region, 2017-2027 (US$ Mn)
10.5.1. Market Analysis
10.5.2. Middle East & Africa
10.5.3. Latin America

11. Company Profiles
11.1. bioMerieux SA
11.2. Danaher Corporation
11.3. Guangzhou Wondfo Biotech Co., Ltd
11.4. Siemens AG
11.5. Abbott Laboratories
11.6. Alere, Inc.
11.7. LSI Medience Corporation
11.8. Randox laboratories
11.9. Ortho Clinical Diagnostics
11.10. Hoffmann-La Roche AG
11.11. Thermofisher Scientific
11.12. Bio-Rad Laboratories
* CBDK - Cardiac Biomarker Diagnostic Kits

List of Figures
FIG. 1 Global Cardiac Biomarker Diagnostic Kits (CBDK) Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global CBDK Market Segmentation
FIG. 4 Global CBDK Market, by Product Type, 2018 (US$ Mn)
FIG. 5 Global CBDK Market, Disease Indication, 2018 (US$ Mn)
FIG. 6 Global CBDK Market, by Testing, 2018 (US$ Mn)
FIG. 7 Global CBDK Market, by Geography, 2018 (US$ Mn)
FIG. 8 Attractive Investment Proposition, by Geography, 2018
FIG. 9 Global Market Positioning of Key CBDK Market Manufacturers, 2018
FIG. 10 Global CBDK Market Value Share, by Product Type, 2018 & 2027 (Value %)
FIG. 11 Global Troponin Test Kits CBDK Market, 2017–2027 (US$ Mn)
FIG. 12 Global CK-MB Test Kits CBDK Market, 2017–2027 (US$ Mn)
FIG. 13 Global Myoglobin Test Kits Market, 2017–2027 (US$ Mn)
FIG. 14 Global BNP Test Kit CBDK Market, 2017–2027 (US$ Mn)
FIG. 15 Global C-reactive Protein (hsCRP) CBDK Market, 2017–2027 (US$ Mn)
FIG. 16 Global Other Biomarkers Market, 2017–2027 (US$ Mn)
FIG. 17 Global CBDK Market Value Share, Disease Indication, 2018 & 2027 (Value %)
FIG. 18 Global CBDK Market for Angina Pectoris, 2017–2027 (US$ Mn)
FIG. 19 Global CBDK Market for Myocardial Infraction (MI), 2017–2027 (US$ Mn)
FIG. 20 Global CBDK Market for Cardiac Heart Failure, 2017–2027 (US$ Mn)
FIG. 21 Global CBDK Market Value Share, by Testing, 2018 & 2027 (Value %)
FIG. 22 Global CBDK Market for Laboratory Testing, 2017–2027 (US$ Mn)
FIG. 23 Global CBDK Market for Pont-of-care Testing, 2017–2027 (US$ Mn)
FIG. 24 North America CBDK Market, 2017–2027 (US$ Mn)
FIG. 25 Europe CBDK Market, 2017–2027 (US$ Mn)
FIG. 26 Asia Pacific CBDK Market, 2017–2027 (US$ Mn)
FIG. 27 RoW CBDK Market, 2017–2027 (US$ Mn)

List of Tables
TABLE 1 Market Snapshot: Global Cardiac Biomarker Diagnostic Kits (CBDK) Market
TABLE 2 Impact Indicators
TABLE 3 Impact Analysis of Drivers and Restraints
TABLE 4 Global CBDK Market, by Product Type, 2017–2027 (US$ Mn)
TABLE 5 Global CBDK Market, Disease Indication, 2017–2027 (US$ Mn)
TABLE 6 Global CBDK Market, by Testing, 2017–2027 (US$ Mn)
TABLE 7 Global CBDK Market, by Geography, 2017–2027 (US$ Mn)
TABLE 8 North America CBDK Market, by Product Type, 2017–2027 (US$ Mn)
TABLE 9 North America CBDK Market, Disease Indication, 2017–2027 (US$ Mn)
TABLE 10 North America CBDK Market, by Testing, 2017–2027 (US$ Mn)
TABLE 11 North America CBDK Market, by Country, 2017–2027 (US$ Mn)
TABLE 12 Europe CBDK Market, by Product Type, 2017–2027 (US$ Mn)
TABLE 13 Europe CBDK Market, Disease Indication, 2017–2027 (US$ Mn)
TABLE 14 Europe CBDK Market, by Testing, 2017–2027 (US$ Mn)
TABLE 15 Europe CBDK Market, by Country/Region, 2017–2027 (US$ Mn)
TABLE 16 Asia Pacific CBDK Market, by Product Type, 2017–2027 (US$ Mn)
TABLE 17 Asia Pacific CBDK Market, Disease Indication, 2017–2027 (US$ Mn)
TABLE 18 Asia Pacific CBDK Market, by Testing, 2017–2027 (US$ Mn)
TABLE 19 Asia Pacific CBDK Market, by Country/Region, 2017–2027 (US$ Mn)
TABLE 20 Rest of the World CBDK Market, by Product Type, 2017–2027 (US$ Mn)
TABLE 21 Rest of the World CBDK Market, Disease Indication, 2017–2027 (US$ Mn)
TABLE 22 Rest of the World CBDK Market, by Testing, 2017–2027 (US$ Mn)
TABLE 23 Rest of the World CBDK Market, by Region, 2017–2027 (US$ Mn)
TABLE 24 bioMerieux SA: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 25 Danaher Corporation: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 26 Guangzhou Wondfo Biotech Co., Ltd: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 27 Siemens AG: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 28 Abbott Laboratories: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 29 Alere, Inc..: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 30 LSI Medience Corporation: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 31 Randox laboratories: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 32 Ortho Clinical Diagnostics: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 33 Hoffmann-La Roche AG: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 34 Bio-Rad Laboratories: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 35 Thermofisher Scientific: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • bioMerieux SA
  • Danaher Corporation
  • Guangzhou Wondfo Biotech Co., Ltd
  • Siemens AG
  • Abbott Laboratories
  • Alere, Inc.
  • LSI Medience Corporation
  • Randox laboratories
  • Ortho Clinical Diagnostics
  • Hoffmann-La Roche AG
  • Thermofisher Scientific
  • Bio-Rad Laboratories
Note: Product cover images may vary from those shown
Adroll
adroll